Home›Stock Screener›Coral Laboratories›Financial Statements

Coral Laboratories Complete Financial Statements

11 Years of Data
2025 - 2015

In FYNone, Coral Laboratories (CORALAB) reported revenue ₹98 Cr, net profit ₹14 Cr and EPS ₹39.10, with a net profit margin of 19.4% and ROE of 11.9%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see CORALAB screener.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 19.35% 2025 data
EBITDA Margin 28.23% 2025 data
Operating Margin 23.00% 2025 data
Return on Assets 10.43% 2025 data
Return on Equity 11.94% 2025 data

Balance Sheet Ratios

Current Ratio 59.00 2025 data
Equity Ratio 87.39% 2025 data
Asset Turnover 0.54 2025 data

CORALAB Revenue, Net Profit & EBITDA — Year-on-Year Growth

CORALAB YoY (March 2025 vs Period) — revenue -21.0%, net profit -41.7%, EBITDA -40.0%, expenses -13.5%. Explore Coral Laboratories intrinsic price to estimate fundamental worth using multiple valuation models.

Revenue Growth
-21.0%
Year-over-Year
Net Profit Growth
-41.7%
Year-over-Year
EBITDA Growth
-40.0%
Year-over-Year
Expense Growth
-13.5%
Year-over-Year
Assets Growth
+11.7%
Year-over-Year
Equity Growth
+12.9%
Year-over-Year
Operating Cash Flow Growth
+83.3%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year

CORALAB Income Statement — Revenue, EBITDA & Net Profit

Coral Laboratories revenue ₹98 Cr, EBITDA ₹21 Cr, net profit ₹14 Cr, EPS ₹39.10 (None) — net profit margin 19.4%. Review CORALAB P/E comparison to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 98 124 90 85 80 100 77 96 97 99 80 62
Expenses 77 89 67 74 67 81 65 79 77 72 61 47
EBITDA 21 35 23 11 13 20 11 17 20 27 19 15
Operating Profit Margin % 13.00% 23.00% 19.00% 5.00% 11.00% 16.00% 8.00% 13.00% 16.00% 24.00% 21.00% 21.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 19 33 21 8 12 18 9 16 18 25 17 12
Tax 5 8 5 2 3 4 2 5 6 8 5 3
Net Profit 14 24 16 6 9 14 7 10 12 16 12 10
Earnings Per Share (₹) 39.10 67.61 44.19 18.04 25.32 37.94 19.96 28.60 34.84 45.61 34.70 26.79

CORALAB Balance Sheet — Assets, Liabilities & Shareholders' Equity

CORALAB total assets ₹230 Cr, total equity ₹201 Cr, total liabilities ₹ Cr (2025) — ROE 11.9%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 230 206 174 190 168 144 136 140 131 90 72
Current Assets 177 154 124 131 129 96 84 72 74 65 50
Fixed Assets 23 24 25 24 21 23 23 22 18 18 19
Capital Work in Progress 3 0 0 2 1 0 0 0 0 0 0
Investments 52 50 41 46 33 25 28 45 39 0 0
Other Assets 152 132 108 118 112 97 85 73 74 71 54
LIABILITIES
Total Liabilities
Current Liabilities 3 3 8 8 3 4 4 4 4 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 201 178 155 156 137 116 114 116 109 70 59
Share Capital 4 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 198 174 151 153 133 112 110 113 106 67 56

CORALAB Cash Flow Statement — Operating, Investing & Financing

Coral Laboratories operating cash flow ₹-1 Cr, investing ₹0 Cr, financing ₹3 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -1 -6 13 6 1 -4 -1 14 11 5 0
Investing Activities 0 1 -3 -6 0 -2 3 -13 -10 -3 -1
Financing Activities 3 0 -6 0 0 4 -1 -3 1 0 0
Net Cash Flow 1 -4 4 0 1 -2 1 -2 2 2 0